Drug Development in the 21st Century

7th Latin American Conference on Lung Cancer

Richard B. Gaynor, MD

NICE: It Takes Two to Tango

What’s New from the 2016 ESMO Clinical Guidelines

Update to the “Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors”

Victorian Comprehensive Cancer Centre

From the Editor - Corey J. Langer

Paul A. Bunn, Jr, MD: Recipient of 2016 Karnofsky Award

National Comprehensive Cancer Network NSCLC Guideline Updates for 2016: Non-Small Cell Lung Cancer

Welcome from David Carbone, MD, PhD, IASLC President

From the Editor / Corey J. Langer, MD, FACP